A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Habitant morbi tristique senectus et netus. Rutrum tellus pellentesque eu tincidunt tortor aliquam nulla facilisi cras.

Dr. C. Kent Kwoh will lead a study that seeks to develop methods to predict who will experience rapid knee deterioration or need knee replacements in the future.

The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis, according to results of the phase 3 trial.

Researchers at the UArizona Arthritis Center are undertaking a study that seeks to identify determinants of rapid knee deterioration thanks to a $3.4 million grant from the National Institutes of Health.

Recovery support specialists inspire hope and support individuals with mental health, substance use disorder or trauma-related issues.

Several College of Nursing faculty who also are alumni reflect on how the college and nursing have been transformed over more than six decades.

The identification of predictive and prognostic biomarkers has become increasingly important in the diagnosis and treatment of ovarian cancers, especially as newer biomarkers emerge.

As part of the fight against the opioid crisis, the UArizona Center for Rural Health offers free training on how to apply naloxone and what to do in an emergency.